Alkermes ALKS
NASDAQ ALKS
$45.43 -0.06 (-0.13%)
As of: Sep 9, 2026 · 1:23 PM EDT

Alkermes (ALKS) Other Operating Expenses (2010 - 2026)

Alkermes' (ALKS) quarterly Other Operating Expenses came in at $105.7 million in Q2 2026, up 1768.56% year-over-year from $5.7 million in Q2 2025, and up 402.34% quarter-over-quarter from $21.0 million in Q1 2026.

Analysis

Alkermes (ALKS) Other Operating Expenses (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Other Operating Expenses for 17 consecutive years, with $105.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Operating Expenses rose 1768.56% year-over-year to $105.7 million in Q2 2026; TTM through Jun 2026 was $163.4 million, a 254.29% increase from a year earlier, with the FY2025 full-year figure at $40.4 million, down 11.27% from the prior year.
  • Other Operating Expenses was $105.7 million for Q2 2026 at Alkermes, up from $21.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $105.7 million in Q2 2026 and troughed at -$140.2 million in Q4 2023.
  • A 5-year average of $15.3 million and a median of $17.7 million in 2025 frame the typical range for Other Operating Expenses.
  • Across the five-year window, Other Operating Expenses sank 1591.94% in 2022 and jumped 8192.76% in 2023, its largest moves.
  • Over 5 years, Other Operating Expenses stood at -$3.6 million in 2022, then sank by 3846.69% to -$140.2 million in 2023, then surged by 115.27% to $21.4 million in 2024, then declined by 11.4% to $19.0 million in 2025, then soared by 456.85% to $105.7 million in 2026.
  • The last three Other Operating Expenses figures came in at $105.7 million (Q2 2026), $21.0 million (Q1 2026), and $19.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn
7 Revolution Medicines 44.21 Bn 44.21 Bn -
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.67 Mn
Mar 31, 2026 21.04 Mn
Dec 31, 2025 18.98 Mn
Sep 30, 2025 17.70 Mn
Jun 30, 2025 5.66 Mn
Mar 31, 2025 -1.92 Mn
Dec 31, 2024 21.42 Mn
Sep 30, 2024 20.96 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 1.70 Mn
Dec 31, 2023 -140.23 Mn
Sep 30, 2023 70.49 Mn
Jun 30, 2023 72.15 Mn
Mar 31, 2023 66.96 Mn
Sep 30, 2022 -3.55 Mn
Jun 30, 2022 870,000.00
Mar 31, 2022 -19.07 Mn
Dec 31, 2021 -750,000.00
Sep 30, 2021 -5.20 Mn
Jun 30, 2021 3.24 Mn